Nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease (IBD)
View Patent ↗A nutritional composition promotes musculoskeletal health in patients with inflammatory bowel disease. The nutritional composition contains casein protein, vitamin D, alpha-linolenic acid, and vitamin K in a ratio of vitamin K1:vitamin K2 between 3:1 to 1:3 and the vitamin K providing between 3.5-20 μg/100 cal of the nutritional composition. A pharmaceutical formulation, a nutritional formulation, a tube-feed formulation, a dietary supplement, a functional food, a beverage product or a combination thereof comprising the nutritional composition is also disclosed. A method for improving musculoskeletal health is also disclosed.
1. A method of improving musculoskeletal health in patients, the method comprising:
administering to a patient in need of same a nutritional composition comprising acid casein protein, vitamin K at a ratio of vitamin K1:K2 between 3:1 to 1:3 and the vitamin K present in an amount of between 17.5 to 100 μg/100 g of the nutritional composition, vitamin D present in an amount of between 2.5 to 75 μg/100 g of the nutritional composition, and n6/n3 fatty acids at a ratio of n6:n3 fatty acids between 5:1 to 1:5.
2. The method of claim 1 , wherein the improving musculoskeletal health is improved bone density.
3. The method of claim 1 , wherein the improving musculoskeletal health is improved muscle cross-sectional area.
4. The method of claim 1 , wherein the nutritional composition is in an administrable form selected from the group consisting of a pharmaceutical formulation, a nutritional formulation, a tube-feed formulation, a dietary supplement, a functional food, a beverage product and combinations thereof.
5. The method of claim 1 , wherein the nutritional composition is a complete nutritional composition.
6. The method of claim 1 , wherein the n6 fatty acids are selected from the group consisting of linolenic acid (LA) C18:2, gamma-linolenic acid (GLA) C18:3, eicosadienoic acid C20:2, dihomo-gamma-linolenic acid (DGLA) C20:3, arachidonic acid (AA) C20:4, docosadienoic acid C22:2, adrenic acid C22:4, docosapentaenoic acid C22:5, tetracosatetraenoic acid C24:4, tetracosapentaenoic acid C24:5, calendic acid C18:3, and mixtures thereof.
7. The method of claim 1 , wherein the n3 fatty acids are selected from the group consisting hexadecatrienoic acid (HTA) C16:3, alpha-linolenic acid (ALA) C18:3, stearidonic acid (SDA) C18:4, eicosatrienoic acid (ETE) C20:3, eicosatetraenoic acid (ETA) C20:4, eicosapentaenoic acid (EPA) C20:5, heneicosapentaenoic acid (HPA) C21:5, docosapentaenoic acid (DPA) C22:5, docosahexaenoic acid (DHA) C22:6, tetracosapentaenoic acid C24:5, tetracosahexaenoic acid C24:6, and mixtures thereof.
8. The method of claim 1 , wherein the nutritional composition further comprises one or more amino acids selected from the group consisting of Alanine, Arginine, Asparagine, Aspartate, Citrulline, Cysteine, Glutamate, Glutamine, Glycine, Histidine, Hydroxyproline, Hydroxyserine, Hydroxytyrosine, Hydroxylysine, Isoleucine, Leucine, Lysine, Methionine, Phenylalanine, Proline, Serine, Taurine, Threonine, Tryptophan, Tyrosine, Valine, HICA (Alpha-Hydroxyisocaproic Acid), HIVA (Alpha-Hydroxyisovaleric Acid), HIMVA (alpha-hydroxymethylvaleric acid) and combinations thereof.
9. The method of claim 1 , wherein the nutritional composition further comprises one or more additional vitamins selected from the group consisting Vitamin A, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Pantothenic Acid, Vitamin B6, Vitamin B12, Niacin, Folic Acid, Biotin, and Choline, and combinations thereof.